Invenomic Capital Management’s McKesson MCK Stock Holding History

Invenomic Capital Management’s Portfolio MCK Stock Details MCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31,705	Closed	-$7.88M	–	173
2021 Q4	$7.88M	Buy	31,705 +10,637	+50%	+$2.34M	1.68%	16
2021 Q3	$4.2M	Buy	+21,068	New	+$4.21M	1.36%	24
2020 Q3	–	Sell	-1,737	Closed	-$266K	–	162
2020 Q2	$266K	Buy	+1,737	New	+$251K	0.2%	122

Other funds holding MCK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Invenomic Capital Management's MCK Position: Q1 2022 in Review

Invenomic Capital Management sold out of McKesson (MCK) in Q1 2022, closing a stake of 31,705 shares — an estimated $7.88M sold.

Invenomic Capital Management first reported a position in MCK in Q2 2020 and held it in 3 quarters. The position peaked at $7.88M in Q4 2021. 1,139 funds tracked by Wall St. Rank hold MCK as of Q1 2022.

Invenomic Capital Management reported no remaining McKesson position as of Q1 2022 after selling out during the quarter.
Invenomic Capital Management sold 31,705 McKesson shares in Q1 2022, an estimated $7.88M.
Invenomic Capital Management first reported a position in McKesson in Q2 2020 and held it in 3 quarters.
Invenomic Capital Management's McKesson position peaked at $7.88M in Q4 2021.
1,139 funds tracked by Wall St. Rank held McKesson as of Q1 2022.

Based on Invenomic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.